Company intelligence / Profile preview

Calistair

Ownership: Private
Development stage: Commercial

Overview

Calistair has developed a proprietary modular reactor system that uses advanced catalysts and adsorbents to capture airborne contaminants. Their technology is commercially deployed in hospital environments and cleanrooms. The company was recognized among the top 5 Air Purification Startups Impacting Public Safety During the COVID pandemic.

Therapeutic areas: Infectious Diseases
Modalities: DeviceMaterial-based technology
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Calistair.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calistair.

Explore the full profile